Haven venture from Amazon, Berkshire Hathaway, and JPMorgan Chase announces shutdown
In January 2018, Amazon, Berkshire Hathaway, and JPMorgan Chase announced they were collaborating on the challenges of healthcare by launching a new healthcare startup known as Haven Healthcare. Now, a post on the Haven website announced they were ending their independent operations at the end of February 2021.
They described their mission to reduce costs and improve employee satisfaction in healthcare. The Haven website mentioned their goals are to improve the current health system, including easy access to affordable medical treatments and prescription drugs.
Dr. Atul Gawande became the Haven CEO and assembled a leadership team. However, not much has been heard about Haven or their operations in the last three years.
The announcement stated, “In the past three years, Haven explored a wide range of healthcare solutions, as well as piloted new ways to make primary care easier to access, insurance benefits simpler to understand and easier to use, and prescription drugs more affordable.”
“Moving forward, Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. will leverage these insights and continue to collaborate informally to design programs tailored to address the specific needs of their own employee populations.”
